Chronic obstructive pulmonary disease: When pulmonologists do something good for the heart

American Journal of Respiratory and Critical Care Medicine

Volumn 193, Issue 7, 2016, Pages 703-704

  Watz, Henrik ^a,b  

^a Pulmonary Research Institute   (Germany)

^b German Center for Lung Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDACATEROL; OXYGEN; TIOTROPIUM BROMIDE; ANDROSTANE DERIVATIVE; BENZYL ALCOHOL DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHLOROBENZENE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIASTOLE; ECHOCARDIOGRAPHY; EDITORIAL; FORWARD HEART FAILURE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART PERFORMANCE; HEART PRELOAD; HEART RIGHT VENTRICLE VOLUME; HEART STROKE VOLUME; HUMAN; HYPERINFLATION; LUNG BLOOD VOLUME; LUNG EMPHYSEMA; LUNG RESECTION; OXYGENATION; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY VEIN; THORAX PRESSURE; VEIN DIAMETER; EMPHYSEMA; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VOLUME; PULMONOLOGIST; CARDIAC MUSCLE; DRUG EFFECTS; FEMALE; HEART; LUNG; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANDROSTADIENES; BENZYL ALCOHOLS; CHLOROBENZENES; FEMALE; HEART; HUMANS; LUNG; MALE; MYOCARDIUM; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84982095413     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201512-2340ED     Document Type: Editorial

References (28)

1. O'Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:180-184.
2. Casaburi R. Activity promotion: A paradigm shift for chronic obstructive pulmonary disease therapeutics. Proc Am Thorac Soc 2011;8:334-337.
3. Waschki B, Kirsten AM, Holz O, Mueller KC, Schaper M, Sack AL, Meyer T, Rabe KF, Magnussen H, Watz H. Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015;192:295-306.
4. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD 2006;3:219-232.
5. O'Donnell DE, Flüge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, Make B, Magnussen H. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-840.
6. Beeh KM, Watz H, Puente-Maestu L, de Teresa L, Jarreta D, Caracta C, Garcia Gil E, Magnussen H. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: A randomized, placebo-controlled, crossover trial. BMC Pulm Med 2014;14:209.
7. Watz H, Krippner F, Kirsten A, Magnussen H, Vogelmeier C. Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease: A randomized, multicenter, double-blind, placebo-controlled study. BMC Pulm Med 2014;14:158.
8. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of betaagonists in patients with asthma and COPD: A meta-analysis. Chest 2004;125:2309-2321.
9. Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. JAMA 2008;300:1439-1450.
10. Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:543-548.
11. Watz H. The lungs and the heart. Am J Respir Crit Care Med 2015;192:7-8.
12. Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL, Roche N, Similowski T, Watz H, Worth H, et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 2015;109:785-802.
13. Albert RK, Muramoto A, Caldwell J, Koepsell T, Butler J. Increases in intrathoracic pressure do not explain the rise in left ventricular end-diastolic pressure that occurs during exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;132:623-627.
14. Butler J, Schrijen F, Henriquez A, Polu JM, Albert RK. Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis 1988;138:350-354.
15. Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M, Sainty JM, Orehek J. Left atrial and ventricular filling in chronic obstructive pulmonary disease: An echocardiographic and Doppler study. Am J Respir Crit Care Med 2000;162:670-675.
16. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: A cross-sectional study. Am J Respir Crit Care Med 2008;177:743-751.
17. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, Magnussen H. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010;138: 32-38.
18. Grau M, Barr RG, Lima JA, Hoffman EA, Bluemke DA, Carr JJ, Chahal H, Enright PL, Jain A, Prince MR, et al. Percent emphysema and right ventricular structure and function: The Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies. Chest 2013;144:136-144.
19. Jörgensen K, Müller MF, Nel J, Upton RN, Houltz E, Ricksten SE. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: An MRI study. Chest 2007;131:1050-1057.
20. Smith BM, Prince MR, Hoffman EA, Bluemke DA, Liu CY, Rabinowitz D, Hueper K, Parikh MA, Gomes AS, Michos ED, et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs The Multi-Ethnic Study of Atherosclerosis COPD Study. Chest 2013;144:1143-1151.
21. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362:217-227.
22. Cuttica MJ, Colangelo LA, Shah SJ, Lima J, Kishi S, Arynchyn A, Jacobs DR Jr, Thyagarajan B, Liu K, Lloyd-Jones D, et al. Loss of lung health from young adulthood and cardiac phenotypes in middle age. Am J Respir Crit Care Med 2015;192:76-85.
23. Lammi MR, Ciccolella D, Marchetti N, Kohler M, Criner GJ. Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation. Eur Respir J 2012;40:837-843.
24. Jörgensen K, Houltz E, Westfelt U, Nilsson F, Scherstén H, Ricksten SE. Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema. Chest 2003;124:1863-1870.
25. Criner GJ, Scharf SM, Falk JA, Gaughan JP, Sternberg AL, Patel NB, Fessler HE, Minai OA, Fishman AP; National Emphysema Treatment Trial Research Group. Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J Respir Crit Care Med 2007;176:253-260.
26. Travers J, Laveneziana P, Webb KA, Kesten S, O'Donnell DE. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. Respir Med 2007;101:2017-2024.
27. Santus P, Radovanovic D, Di Marco S, Valenti V, Raccanelli R, Blasi F, Centanni S, Bussotti M. Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: An interventional, randomized, double-blind clinical trial. Int J Chron Obstruct Pulmon Dis 2015;10:1917-1923.
28. Stone IS, Barnes NC, James W-Y, Midwinter D, Boubertakh R, Follows R, John L, Petersen SE. Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease: A randomized controlled trial. Am J Respir Crit Care Med 2016;193:717-726.